With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.
A range of GLP-1 weight loss drugs are currently on the market. What are they, what do they do, and where are they available?
People with diabetes who were taking GLP-1 receptor agonist drugs such as tirzepatide and semaglutide had significantly lower ...
During JPM week, virtual care companies strut their plans to make GLP-1 drugs work harder, cost less
Digital health companies' plans focused on managing the impact of GLP-1 drugs, which have placed enormous pressure on health ...
A systematic review of randomized controlled trials (RCTs) assessed the efficacy and safety of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and co-agonists for obesity in adults without ...
Dr. Mehmet Furkan Burak said people who have lost weight and then gained it again can feel guilt or shame and blame ...
This is the beginning of a revolution, and how you engage and how you attack it is going to really set the stage for your ...
The GLP-1s include semaglutide (Ozempic, Wegovy) and the combination of GLP-1/GIP drug tirzepatide (Mounjaro, Zepbound).
For adults with overweight or obesity without diabetes, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are efficacious ...
Achieving and maintaining a healthy weight is beneficial for a number of reasons. A healthy weight lowers a person's chance ...
"Coverage for these weight-loss drugs has significant cost implications for employers, as a previous KFF analysis estimated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback